A2AR as a Prognostic Marker and a Potential Immunotherapy Target in Human Glioma von Rafii, Soumaya, Ghouzlani, Amina, Naji, Oumayma, Ait Ssi, Saadia, Kandoussi, Sarah, Lakhdar, Abdelhakim, Badou, Abdallah

Volltext

Prognostic Gene Expression Signature in Patients With Distinct Glioma Grades von Ssi, Saadia Ait, Chraa, Dounia, El Azhary, Khadija, Sahraoui, Souha, Olive, Daniel, Badou, Abdallah

Volltext

TMIGD2 as a potential therapeutic target in glioma patients von Boulhen, Chaimae, Ait Ssi, Saadia, Benthami, Hamza, Razzouki, Ibtissam, Lakhdar, Abdelhakim, Karkouri, Mehdi, Badou, Abdallah

Volltext

BTN3A: A Promising Immune Checkpoint for Cancer Prognosis and Treatment von Kone, Abdou-samad, Ait Ssi, Saadia, Sahraoui, Souha, Badou, Abdallah

Volltext

NR2F6, a new immune checkpoint that acts as a potential biomarker of immunosuppression and contributes to poor clinical outcome in human glioma von Miftah, Hayat, Naji, Oumayma, Ssi, Saadia Ait, Ghouzlani, Amina, Lakhdar, Abdelhakim, Badou, Abdallah

Volltext

High VISTA expression is linked to a potent epithelial-mesenchymal transition and is positively correlated with PD1 in breast cancer von Rezouki, Ibtissam, Zohair, Basma, Ssi, Saadia Ait, Karkouri, Mehdi, Razzouki, Ibtissam, Elkarroumi, Mohamed, Badou, Abdallah

Volltext

A[sub.2A]R as a Prognostic Marker and a Potential Immunotherapy Target in Human Glioma von Rafii, Soumaya, Ghouzlani, Amina, Naji, Oumayma, Ait Ssi, Saadia, Kandoussi, Sarah, Lakhdar, Abdelhakim, Badou, Abdallah

Volltext

A 2A R as a Prognostic Marker and a Potential Immunotherapy Target in Human Glioma von Rafii, Soumaya, Ghouzlani, Amina, Naji, Oumayma, Ait Ssi, Saadia, Kandoussi, Sarah, Lakhdar, Abdelhakim, Badou, Abdallah

Volltext